Analyses / Public Summary / 119 · HR 2319 Public Summary

119-HR-2319 Journalist Public Summary

119 · HR 2319 Women and Lung Cancer Research and Preventive Services Act of 2025

health_and_safety Health
Women and Lung Cancer Research and Preventive Services Act of 2025This bill requires the Department of Health and Human Services to conduct an interagency review to accelerate lung cancer research,...

A bipartisan House-passed bill would have HHS lead an interagency review to speed research, widen screening access, and boost public awareness on lung cancer in women and underserved groups; the House approved it on April 21, 2026, and it now awaits Senate action. (energycommerce.house.gov)

Published
22 Apr 2026
Updated
22 Apr 2026
Tags
public-summary · US-Congress · health-policy
Unvetted
01 · Section

Public Summary — 119-HR-2319

Headline Summary: The bill orders a federal, cross-agency review to close gaps in lung‑cancer research and screening for women and underserved populations; it passed the House on April 21, 2026, and now heads to the Senate. (energycommerce.house.gov)

What It Does: H.R. 2319 directs the Department of Health and Human Services—working with the Departments of Defense and Veterans Affairs—to evaluate what the federal government is doing on lung‑cancer research related to women and underserved groups, identify gaps and collaboration opportunities, assess access to preventive services and screening, and recommend national strategies for screening and public education. A report to Congress would be due within two years of enactment. The bill’s focus on screening references eligibility criteria used by the U.S. Preventive Services Task Force (e.g., adults 50–80 with a 20 pack‑year smoking history). (govinfo.gov)

  • Who’s For It: Lead sponsors include Rep. Brendan Boyle (D‑PA); cosponsors include Reps. Brian Fitzpatrick (R‑PA) and Juan Ciscomani (R‑AZ). (congress.gov)
  • House Energy & Commerce leaders publicly backed House passage on April 21, 2026. (energycommerce.house.gov)
  • American Cancer Society Cancer Action Network (ACS CAN) has endorsed the measure. (fightcancer.org)
  • In the Senate, a companion bill (S. 1157) advanced out of the Health, Education, Labor & Pensions Committee on January 15, 2026, by a 22–0 vote—signaling bipartisan interest. (help.senate.gov)
  • Who’s Against It: No organized opposition has been publicly documented in official House materials around passage; the measure moved with broad support typical of lower‑controversy bills. (energycommerce.house.gov)

What’s Next: After clearing the House on April 21, 2026, the bill goes to the Senate. Senators could take up H.R. 2319 or proceed with the related S. 1157 that already cleared committee; if the Senate passes a version, the chambers would reconcile any differences before sending it to the President. (energycommerce.house.gov)

Discussion